Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

6.6%

8 terminated out of 122 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

9%

11 trials in Phase 3/4

Results Transparency

11%

4 of 36 completed with results

Key Signals

4 with results82% success

Data Visualizations

Phase Distribution

64Total
Not Applicable (42)
P 1 (3)
P 2 (8)
P 3 (7)
P 4 (4)

Trial Status

Completed36
Unknown36
Recruiting25
Terminated8
Active Not Recruiting8
Not Yet Recruiting6

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 36 completed trials

Clinical Trials (122)

Showing 20 of 20 trials
NCT07528586Not ApplicableRecruitingPrimary

Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy

NCT06183437Phase 4Recruiting

The STOP-MED CTRCD Trial

NCT06778122Not ApplicableRecruiting

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors

NCT05096338Active Not Recruiting

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

NCT06211413Enrolling By Invitation

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

NCT07191730RecruitingPrimary

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

NCT07442578Not ApplicableActive Not Recruiting

Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial

NCT04827563Terminated

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

NCT07158450Enrolling By InvitationPrimary

Novel On-body Evaluation of Cardiac Health for Oncology

NCT07405385Not ApplicableNot Yet Recruiting

Cardiotoxicity Assessment and Reduction Through Exercise in BREAST Cancer

NCT07093918Not Yet RecruitingPrimary

Artificial Intelligence for Reconstruction of Echocardiography Studies

NCT04361240Completed

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

NCT06332131Enrolling By Invitation

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

NCT04026737Completed

Cardiovascular Effects of CART Cell Therapy

NCT07382141Not ApplicableRecruitingPrimary

Early Identification of Cardivascular Damage Induced by Chemotherapy and Antineoplastic Treatments in Pediatric Age

NCT06595147Not ApplicableRecruiting

Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study

NCT06023576Phase 2Recruiting

A Study of Blood Pressure Control During Cancer Treatment

NCT07267247Completed

Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer

NCT04598646Not ApplicableCompleted

The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Pilot Study

NCT05023785Not ApplicableRecruiting

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

Scroll to load more

Research Network

Activity Timeline